Skip to content

Opening book details…

About this Medicine article

Impact of lapatinib plus trastuzumab versus single-agent lapatinib on quality of life of patients with trastuzumab-refractory HER2+ metastatic breast cancer by Wu, Y.; Amonkar, M. M.; Sherrill, B. H.; O'Shaughnessy, J.; Ellis, C.; Baselga, J.; Blackwell, K. L.; Burstein, H. J. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Wu, Y.; Amonkar, M. M.; Sherrill, B. H.; O'Shaughnessy, J.; Ellis, C.; Baselga, J.; Blackwell, K. L.; Burstein, H. J.
Publisher
Oxford University Press; Elsevier BV (ISSN 0923-7534)
Published
2011
Field
Medicine (Health Sciences)

More by Wu, Y.; Amonkar, M. M.; Sherrill, B. H.; O'Shaughnessy, J.; Ellis, C.; Baselga, J.; Blackwell, K. L.; Burstein, H. J.

Browse all works by Wu, Y.; Amonkar, M. M.; Sherrill, B. H.; O'Shaughnessy, J.; Ellis, C.; Baselga, J.; Blackwell, K. L.; Burstein, H. J.